Our AI Platform
Built for Biological Complexity

A fully integrated, multi-layer AI architecture designed for the biological complexity of modern drug discovery.

Most AI tools in drug discovery address a single stage in isolation. Prognica Labs built a fully integrated platform where each layer informs and amplifies the others — creating compounding intelligence across the entire discovery workflow.

Compounds in training data
3 M+
Biological entity relationships
2 B+
ADMET predictive endpoints
40 +
Integrated public databases
50 +
Platform Architecture
Six Integrated Layers
Each layer is independently powerful and collectively transformative.

Layer 01

Data Ingestion &

Harmonisation Layer

We ingest and harmonize public and proprietary multi-omics datasets – genomics, transcriptomics, proteomics, metabolomics – along with clinical, structural biology, and literature data through automated curation pipelines.

Layer 02

Multi-Omics AI
Integration Engine

Our flagship integration engine fuses signals across biological modalities using graph neural networks and multi-modal transformer architectures, surfacing emergent biological insights invisible to single-modality analysis.

Layer 03

Generative Chemistry Platform

Proprietary generative models trained on 120M+ compounds produce novel, synthesizable molecules optimized across multiple drug-like properties simultaneously, moving beyond analog-based medicinal chemistry.

Layer 04

Predictive Modeling Suite

Ensemble ML models predict ADMET properties, binding affinity, selectivity, and PK/PD parameters with validated accuracy across >85% of endpoints, reducing in vitro and in vivo screening burden significantly.

Layer 05

Explainable AI (XAI) Framework

Every prediction in our platform is accompanied by mechanistic rationale – attention maps, feature importance scores, and biological pathway annotations – enabling scientific trust and regulatory confidence.

Layer 06

Discovery Orchestration & Workflow Automation

An intelligent workflow engine connects all platform components into automated, adaptive discovery loops – routing compounds and targets through the right analyses at the right time, minimizing manual handoffs.

Contact us with your own compound or disease target for a demo.